Novalis LifeSciences
Venture capitalPortsmouth · Seed–Late Stage · 9 people tracked
Investment thesis
Novalis Advisory provides strategic advisory and investment banking services, including consulting on business organization and operations, financial and management matters, and executive and leadership development training and coaching.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & public directories
What they invest in
from 13 of 17 portfolio companiesBiotech ×9AI & Machine Learning ×8Medical Devices ×7Healthtech ×5Deep Tech ×4AgTech ×3Digital Health ×2Data & Infrastructure ×1
HQs:United States×10
Investments · 17 tracked
founders shown can be your intro pathBy year:2025 · 22023 · 12022 · 12021 · 12020 · 22019 · 12017 · 19 dated
Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
John Connolly(Director)Douglas Cole(Director)David Walt(Director)Martin Madaus(Director)Dennis Sandstedt(Director)Ernest Orticerio(Executive Officer)
Board seatMarijn DekkersPaul Meister· per SEC Form D · $6.5M raise · filed Jul 2019
Activ Surgical develops digital surgery imaging technology that uses augmented reality, artificial intelligence, and machine learning to help surgeons visualize critical physiological structures during surgery.
AI & Machine LearningHealthtechMedical DevicesBoston, US
Michael Ruehlman(Executive Officer)Emily Casey(Director)David Wells(Director)Peter Kim(Director)Todd Usen(Executive Officer, Director)
BoardAshok Krishnamurthi(Director)
Board seatPaul Meister· per SEC Form D · $15M raise · filed Jul 2020
AgTechResearch Triangle Park, US
Scott Uknes(Manager)Larry Robbins(Secretary)Thomas Dietz(Manager)John Ryals(Manager)Paul Schulze-Lefert(President)Michael Koziel(Vice President and Manager)
Board seatMarijn Dekkers· per SEC Form D · $117.2M raise · filed Feb 2022
Animol Discovery develops small-molecule pharmaceuticals for companion and farm animals, targeting unmet veterinary needs.
AgTechAI & Machine LearningBiotechBoston, US
Philip Austin(Executive Officer, Director)Andrew Plant(Executive Officer, Director)
BoardMichelle Haven(Director)
Board seatMarijn Dekkers· per SEC Form D
BiotechBoston, US
Philip Austin(Director)Steffen Helmling(Director)Jacqueline Heard(Executive Officer, Director)
Board seatMarijn Dekkers· per SEC Form D · $80M raise · filed Dec 2022
Flywheel provides a platform for organizing, managing, and sharing medical imaging data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US
Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)Colby Moosman(Executive Officer)Matthew D. Michela(Executive Officer, Director)Sarah Fazio(Executive Officer)Danny J. Cunagin(Director)
Board seatMarijn DekkersPaul MeisterDevin Leake· per SEC Form D
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)Jiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)Robert Carson(Executive Officer, Director)Terry Lo(Director)Seth Benson(Executive Officer)Simona Levi(Executive Officer)
Board seatMarijn Dekkers· per SEC Form D · $37M raise · filed Apr 2021
Synecta develops cell-derived nanoparticles that activate immune cells for cell therapy manufacturing, improving potency and reducing costs.
BiotechDeep TechMedical DevicesPhiladelphia, US
Peter Keller(Executive Officer, Director)
BoardPaul Meister(Director)Elaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)
Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases.
AgTechAI & Machine LearningBiotech
Tom Meade(Chief Science Officer)
Orogen Therapeutics is a drug discovery company that uses AI-enabled DNA-encoded library (DEL) technology and machine learning to identify novel small-molecule compounds targeting cytokine-related immuno-inflammatory disorders.
AI & Machine LearningBiotechDeep Tech
Mark Pykett(CEO)
Telesis Bio develops automated platforms for RNA and DNA synthesis to accelerate therapeutic discovery workflows in drug development, cell and gene therapy, and vaccine development.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
Franklin R. Witney(Chair of the Board of Directors)Eric Esser(Executive Officer)William F. Snider(Director)Andrea L. Jackson(Director)Christine A. Tsingos(Director)Robert H. Cutler(Executive Officer)
BiotechDigital HealthMedical DevicesMiami, US
Matthew H. J. Kim(Executive Officer, Director)Timothy Barabe(Director)Eric Stone(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioQuanterixNASDAQ: QTRX
Portfolio news
latest coverage across their companiesFlywheel Exchange, Inc. · wenatcheeworld.com · Jul 1, 2026
Vizgen · intelligence360.news · Feb 2, 2026
Enko Website · globenewswire.com · Nov 22, 2025
Frequently asked questions
- What stage does Novalis LifeSciences invest at?
- Novalis LifeSciences invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Novalis LifeSciences focus on?
- Novalis LifeSciences focuses on Biotech, Healthtech, Medical Devices.
- Where is Novalis LifeSciences located?
- Novalis LifeSciences is headquartered in Portsmouth, US.
Images
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.